doq.nl
Jun 26, 2025, 12:51
Heleen van Ommen Shares ISTH2025 Data on Edoxaban in Children with VTE
Heleen van Ommen, chair of the International Pediatric Thrombosis Network (IPTN), posted on X:
“ISTH2025 Efficacy and safety outcomes were comparable between edoxaban and standard of care in pediatric VTE patients according to Mihir Bhatt. Unfortunately, pre-defined non- inferiority margin was not met.”
Find similar posts on Hemostasis Today.
-
Sep 4, 2026, 18:22Tareq Abadl: The Clinical Meaning of C3 and C4
-
Sep 4, 2026, 18:16How Mutant p53 Hijacks VWF Expression in Tumor Cells – JTH
-
Sep 4, 2026, 18:08Simon Kraler: Can the Adrenomedullin System Predict Cardiogenic Shock Before It Happens?
-
Sep 4, 2026, 17:56Maxime Dely: Why Every Blood Donation Matters
-
Sep 4, 2026, 17:28Shinya Goto: When Cardiovascular Risk Gets Lower, RCTs Get Harder
-
Sep 4, 2026, 16:55New Orleans Is Calling ASH26 Is Near
-
Sep 4, 2026, 16:48ESC Congress 2026 – My Top 20 Lipidology Highlights Shaping the Future of Cardiovascular Prevention – Pablo Corral
-
Sep 4, 2026, 16:38Felice Gragnano։ Turning Cardiovascular Risk Into Action
-
Sep 4, 2026, 16:30Lisa Littner: The Hidden Burden of Prior Authorization in Bleeding Disorder Care